Table 4 Quality assessment of trials of magnesium sulphate in pregnancies with preeclampsia
From: Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths
| Â | Quality Assessment | Summary of Findings | ||||||
|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Directness | No of events | Â | ||
No of studies (ref) | Design | Limitations | Consistency | Generalizability to population of interest | Generalizability to intervention of interest | Intervention | Control | Relative Risk (95% CI) |
Stillbirths: HIGH/MODERATE outcome specific quality | ||||||||
3 | RCT | None | Consistent; Low heterogeneity (p=0.34); Results statistically insignificant | 2 studies in developing countries | Yes | 424 | 426 | 0.99 (0.87, 1.12) |
Perinatal mortality: HIGH/MODERATE outcome specific quality | ||||||||
2 | RCT | None | Consistent; Low heterogeneity (p=0.45); Results statistically insignificant | 1 study in developing country | Yes | 538 | 541 | 0.98 (0.88, 1.10) |